The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 77,329,500 | 2,325,000 | SH | SOLE | 2,325,000 | 0 | 0 | ||
| ALKERMES PLC | SHS | G01767105 | 70,094,500 | 2,450,000 | SH | SOLE | 2,450,000 | 0 | 0 | ||
| APOGEE THERAPEUTICS INC | COM | 03770N101 | 12,594,700 | 290,000 | SH | SOLE | 290,000 | 0 | 0 | ||
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | 2,410,170 | 483,000 | SH | SOLE | 483,000 | 0 | 0 | ||
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | 10919W405 | 13,055,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 70,207,500 | 3,450,000 | SH | SOLE | 3,450,000 | 0 | 0 | ||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 43,339,517 | 3,298,289 | SH | SOLE | 3,298,289 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM NEW | 171757206 | 57,234,250 | 1,175,000 | SH | SOLE | 1,175,000 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 16,594,158 | 2,311,164 | SH | SOLE | 2,311,164 | 0 | 0 | ||
| CRESCENT BIOPHARMA INC. | COM | G2545C104 | 7,322,492 | 453,686 | SH | SOLE | 453,686 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | 17,461,521 | 7,692,300 | SH | SOLE | 7,692,300 | 0 | 0 | ||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 94,137,749 | 4,692,809 | SH | SOLE | 4,692,809 | 0 | 0 | ||
| INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | 10,525,102 | 5,397,488 | SH | SOLE | 5,397,488 | 0 | 0 | ||
| KYMERA THERAPEUTICS INC | COM | 501575104 | 32,730,000 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 185,415,000 | 3,525,000 | SH | SOLE | 3,525,000 | 0 | 0 | ||
| MIND MEDICINE MINDMED INC | COM NEW | 60255C885 | 32,450,000 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | ||
| NEUROGENE INC | COM | 64135M105 | 6,396,597 | 427,866 | SH | SOLE | 427,866 | 0 | 0 | ||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 44,975,158 | 3,948,653 | SH | SOLE | 3,948,653 | 0 | 0 | ||
| NUVALENT INC | COM | 670703107 | 104,912,500 | 1,375,000 | SH | SOLE | 1,375,000 | 0 | 0 | ||
| ORUKA THERAPEUTICS INC | COM | 687604108 | 15,914,994 | 1,419,714 | SH | SOLE | 1,419,714 | 0 | 0 | ||
| PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | G70077105 | 7,965,000 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| PHARVARIS N V | COM | N69605108 | 33,641,221 | 1,911,433 | SH | SOLE | 1,911,433 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 59,415,250 | 1,075,000 | SH | SOLE | 1,075,000 | 0 | 0 | ||
| RELAY THERAPEUTICS INC | COM | 75943R102 | 46,191,000 | 13,350,000 | SH | SOLE | 13,350,000 | 0 | 0 | ||
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | 51,359,000 | 1,450,000 | SH | SOLE | 1,450,000 | 0 | 0 | ||
| SOLENO THERAPEUTICS INC | COM | 834203309 | 51,105,800 | 610,000 | SH | SOLE | 610,000 | 0 | 0 | ||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 29,761,617 | 1,988,084 | SH | SOLE | 1,988,084 | 0 | 0 | ||
| TANGO THERAPEUTICS INC | COM | 87583X109 | 7,680,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| TYRA BIOSCIENCES INC | COM | 90240B106 | 29,667,000 | 3,100,000 | SH | SOLE | 3,100,000 | 0 | 0 | ||
| VERA THERAPEUTICS INC | CL A | 92337R101 | 18,848,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 68,152,500 | 4,875,000 | SH | SOLE | 4,875,000 | 0 | 0 | ||
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | 3,150,000 | 1,575,000 | SH | SOLE | 1,575,000 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 94,682,500 | 3,025,000 | SH | SOLE | 3,025,000 | 0 | 0 | ||